By: Emily MacHale
Tustin, CA – Integrium, LLC Executives will attend RESI on MaRS 2017 in Toronto, Canada on April 4, 2017. Hosted each year, RESI is notorious for providing meetings for hungry fundraisers and allowing them to connect with eager life science investors. Guests will also be able to hear from investors and their firsthand experience with the investing process and the best tactics for qualifying candidates.
RESI gives Integrium Executives the chance to market their products and services to fundraisers in the life sciences field in hopes to find ways to collaborate on various levels. Through powerful synergy discussions and room for networking, Integrium Executives are always able to create new relationships with biotechs, medical device companies, investors, and more.
Integrium Executives will be available for meetings at various times throughout RESI. Details are upon meeting request. To reserve a timeslot to meet with Integrium, click below or contact Emily MacHale at email@example.com.
Integrium helps Micro Cap, Small Cap, and Privately held Biotechs within the Generic and Innovator space attain clinical data so they can raise the next round of capital. lntegrium's areas of therapeutic focus include Cardiovascular, Metabolic, Renal, Inflammatory, Dermatology, Wound Healing, Gene Therapy, and Orphan Diseases. Secondary specialties include Schedule 2 drugs and Oncology
To learn more about Integrium, contact:
Associate Director of Marketing & Research